These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29722002)

  • 1. Genetics of metastasis: melanoma and other cancers.
    Turner N; Ware O; Bosenberg M
    Clin Exp Metastasis; 2018 Aug; 35(5-6):379-391. PubMed ID: 29722002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis.
    Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P
    PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma.
    Ekedahl H; Lauss M; Olsson H; Griewank KG; Schadendorf D; Ingvar C; Jönsson G
    Pigment Cell Melanoma Res; 2016 Sep; 29(5):598-600. PubMed ID: 27301352
    [No Abstract]   [Full Text] [Related]  

  • 4. Your patient with melanoma: staging, prognosis, and treatment.
    Rubin KM; Lawrence DP
    Oncology (Williston Park); 2009 Jul; 23(8 Suppl):13-21. PubMed ID: 19860037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous malignant melanoma.
    Cummins DL; Cummins JM; Pantle H; Silverman MA; Leonard AL; Chanmugam A
    Mayo Clin Proc; 2006 Apr; 81(4):500-7. PubMed ID: 16610570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic pathways to melanoma tumorigenesis.
    Hussein MR
    J Clin Pathol; 2004 Aug; 57(8):797-801. PubMed ID: 15280398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular classification and markers of malignant melanoma].
    Tímár J; Hársing J; Somlai B
    Magy Onkol; 2013 Jun; 57(2):73-8. PubMed ID: 23795351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased risk of developing a second primary cutaneous nevus-associated melanoma in patients previously diagnosed with the disease].
    Echeverría B; Botella-Estrada R; Serra-Guillén C; Martorell A; Traves V; Requena C; Sanmartín O; Llombart B; Guillén C; Nagore E
    Actas Dermosifiliogr; 2010 Oct; 101(8):710-6. PubMed ID: 20965014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent discoveries in the genetics of melanoma and their therapeutic implications.
    Marquette A; Bagot M; Bensussan A; Dumaz N
    Arch Immunol Ther Exp (Warsz); 2007; 55(6):363-72. PubMed ID: 18060370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of malignant melanomas.
    Kousseff BG
    Ann Plast Surg; 1992 Jan; 28(1):11-3. PubMed ID: 1642397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
    van der Rhee JI; Krijnen P; Gruis NA; de Snoo FA; Vasen HFA; Putter H; Kukutsch NA; Bergman W
    J Am Acad Dermatol; 2011 Aug; 65(2):281-288. PubMed ID: 21570156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological prognostic factors of malignant melanoma].
    Plótár V; Orosz Z; Tóth E; Szentirmay Z
    Magy Onkol; 2007; 51(1):39-46. PubMed ID: 17417674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
    Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
    J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
    Ireland A; Millward M; Pearce R; Lee M; Ziman M
    Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Confocal Morphologic Classification and Clinical Phenotypes of Multiple Primary and Familial Melanomas.
    Grazziotin TC; Alarcon I; Bonamigo RR; Carrera C; Potrony M; Aguilera P; Puig-Butillé JA; Brito J; Badenas C; Alós L; Malvehy J; Puig S
    JAMA Dermatol; 2016 Oct; 152(10):1099-1105. PubMed ID: 27579522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging molecular targets in melanoma invasion and metastasis.
    Orgaz JL; Sanz-Moreno V
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):39-57. PubMed ID: 23095214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma: a clinical review.
    Brown TJ; Nelson BR
    Cutis; 1999 May; 63(5):275-8, 281-4. PubMed ID: 10349543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy.
    Saroufim M; Habib RH; Gerges R; Saab J; Loya A; Amr SS; Sheikh S; Satti M; Oberkanins C; Khalifeh I
    Exp Mol Pathol; 2014 Dec; 97(3):315-20. PubMed ID: 25236573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.